Skip to main content
. Author manuscript; available in PMC: 2013 Mar 28.
Published in final edited form as: Vaccine. 2012 Feb 5;30(15):2570–2581. doi: 10.1016/j.vaccine.2012.01.074

Fig. 1.

Fig. 1

GLA-mediated activation of mouse BMDCs in vitro. A. FACS analysis of surface antigen presentation and costimulatory molecules of CD11c+ BMDCs from wild-type mouse (left) and TLR4-/- mouse (right) treated with aqueous GLA (solid line) or aqueous formulation lacking GLA (shaded area) for 24 h. Representative data from triplicate cultures is shown. B. Secretion of cytokines and chemokines of BMDC cultures from wild-type (black bar) and TLR4-/- mice (white bar) treated with (+) or without (□) GLA. Mean secretion +/- SD of triplicate culture is shown.